Neurovia, Inc. — Form D/A
Neurovia, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2017-05-25. $13.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-05-25
- Form: D/A
- Accession: 0001659474-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $13.9M
- Minimum investment: $25K
- Investors: 8
- Date of first sale: 2015-11-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-252188
Issuer
- Name: Neurovia, Inc.
- CIK: 0001659474
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1700 OWENS STREET, SUITE 525, SAN FRANCISCO, CA, 94158
- Phone: 415-254-2232
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Giovanni Ferrara | Director | San Francisco, CA |
| Jason S Hafler | Director | San Francisco, CA |
| Thomas S Scanlan | Director | San Francisco, CA |
| Henry S Skinner | Director | San Francisco, CA |
| Giovanni Ferrara | Executive Officer | San Francisco, CA |
| Thomas S Scanlan | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More